| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |